FDA Says Diabetic Foot Gel Could Cause Cancer

Law360, New York (March 28, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration is stepping up its investigations of a foot gel used by diabetics for leg wounds that may increase the risk of cancer and death, the agency said on Thursday.

The FDA said that a study of Johnson & Johnson Co.'s Regranex found that patients who had been prescribed the gel three or more times were more likely to get a fatal form of cancer.

Regranex, approved in 1997, is used by diabetes patients to help heal leg and foot wounds....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.